Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients

Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients. J Clin Oncol. 2008; 26(May 20 suppl):abstr 11077.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.